TH41567A - Methods and mixtures for the treatment and prevention of blood disease contain too much uric acid. - Google Patents
Methods and mixtures for the treatment and prevention of blood disease contain too much uric acid.Info
- Publication number
- TH41567A TH41567A TH9801004479A TH9801004479A TH41567A TH 41567 A TH41567 A TH 41567A TH 9801004479 A TH9801004479 A TH 9801004479A TH 9801004479 A TH9801004479 A TH 9801004479A TH 41567 A TH41567 A TH 41567A
- Authority
- TH
- Thailand
- Prior art keywords
- uric acid
- prevention
- treatment
- much uric
- blood
- Prior art date
Links
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title claims abstract 6
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title claims abstract 4
- 229940116269 uric acid Drugs 0.000 title claims abstract 4
- 230000002265 prevention Effects 0.000 title claims abstract 3
- 208000019838 Blood disease Diseases 0.000 title claims 2
- 208000014951 hematologic disease Diseases 0.000 title claims 2
- 208000018706 hematopoietic system disease Diseases 0.000 title claims 2
- 239000000203 mixture Substances 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract 7
- 229940125396 insulin Drugs 0.000 claims abstract 4
- 102000004877 Insulin Human genes 0.000 claims abstract 3
- 108090001061 Insulin Proteins 0.000 claims abstract 3
- 229940079593 drug Drugs 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 3
- 239000003795 chemical substances by application Substances 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 3
- MJAMNJNCEOHYIU-UHFFFAOYSA-N 1,2-oxazolidine-3,4-dione Chemical class O=C1CONC1=O MJAMNJNCEOHYIU-UHFFFAOYSA-N 0.000 claims 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 1
- -1 iminothiazole compound Chemical class 0.000 claims 1
- YDCVQGAUCOROHB-UHFFFAOYSA-N oxadiazolidine-4,5-dione Chemical class O=C1NNOC1=O YDCVQGAUCOROHB-UHFFFAOYSA-N 0.000 claims 1
- COWNFYYYZFRNOY-UHFFFAOYSA-N oxazolidinedione Chemical class O=C1COC(=O)N1 COWNFYYYZFRNOY-UHFFFAOYSA-N 0.000 claims 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- 235000019157 thiamine Nutrition 0.000 claims 1
- 239000011721 thiamine Substances 0.000 claims 1
- 230000035899 viability Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract 4
- 210000004369 blood Anatomy 0.000 abstract 4
- 201000005569 Gout Diseases 0.000 abstract 2
- 208000009911 Urinary Calculi Diseases 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000017169 kidney disease Diseases 0.000 abstract 2
- 208000008281 urolithiasis Diseases 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Abstract
DC60 (16/02/42) สารทำให้ความว่องไวของอินซูลินสูงขี้น เช่น โทรกลิทาโซน มีความสามารถสำหรับใช้ รักษา และ/หรือ ป้องกันโลหิตมีกรดยูริ คมากเกินไป ดังนั้น จึงอาจใช้ในการรักษาหรือป้องกัน โรคต่าง ๆ เช่น เก๊าท์, นิ่วในปัสสาวะ, โรคไตที่เกิดจากโลหิตมีกรด ยูริคมากเกินไป, และกลุ่มอา การเลช-ไนแฮน สารทำให้ความว่องไวของอินซูลินสูงขี้น เช่น โทรกลิทาโซน มีความสามารถสำหรับใช้รักษา และ/หรือ ป้องกันโลหิตมีกรดยูริ คมากเกินไป ดังนั้น จึงอาจใช้ในการรักษาหรือป้องกันโรคต่าง ๆ เช่น เก๊าท์, นิ่วในปัสสาวะ, โรคไตที่เกิดจากโลหิตมีกรด ยูริคมากเกินไป, และกลุ่มอาการเลช-ไนแฮน สิทธิบัตรยา DC60 (16/02/42) High-insulin-inhibiting agents such as troglithazone have the ability to treat and / or prevent blood, having too much uric acid, so it may be used for treatment or prevention. Diseases such as gout, urinary stones, kidney disease caused by acidic blood. Too much uric, and the arachnoid-nihan group, substances that cause high insulin reactivity, such as troglithazone, have the ability to treat and / or prevent the blood having too much uric acid. It may be used to treat or prevent diseases such as gout, urinary stones, kidney disease caused by acidic blood. Too much uric, and Lech-Nihan syndrome patent drugs
Claims (3)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH41567A true TH41567A (en) | 2000-11-30 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Johnson et al. | Secretin: the enterogastrone released by acid in the duodenum | |
| RU2314126C2 (en) | Combination of inhibitor (inhibitors) of sterol absorption with modifier (modifiers) of blood designated for treatment of vessel pathological state | |
| BR0013540A (en) | Pharmaceutical formulations and their use in preventing stroke, diabetes and / or congestive heart failure. | |
| DE60038162D1 (en) | CELECOXIB IN SOLID BODY FORM WITH INCREASED BIOAVAILABILITY | |
| BR9810841A (en) | Alicyclic metalloprotease inhibitors | |
| EA200000468A1 (en) | THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY | |
| Petersen et al. | Chronic pain treatment with intravenous lidocaine | |
| DE60234577D1 (en) | PHARMACEUTICAL MIXTURE FOR THE TREATMENT OF CANCER CONTAINING DIOXOLANE NUCLEOSIDE ANALOGUE | |
| PT97300A (en) | PROCESS FOR THE PREPARATION OF N-ALKYLATED 1,4-DIHYDROPYRIDINOCARBOXYL ACID ESTERS AND MEDICINES CONTAINING THEM | |
| RU99119233A (en) | PHARMACEUTICAL COMPOSITIONS containing ibuprofen and domperidone for the treatment of migraine | |
| WO2005004854A3 (en) | Use of betaine for treating arteritis | |
| TW200616644A (en) | Medicine for prevention or treatment of diabetes | |
| TH41567A (en) | Methods and mixtures for the treatment and prevention of blood disease contain too much uric acid. | |
| DK0799618T3 (en) | Use of alpha1 adrenoreceptor antagonists in the manufacture of a drug for the prevention and treatment of cancer | |
| RU2007133435A (en) | METHOD OF COMBINED TREATMENT AND APPLICABLE FOR THIS COMBINATION OF MEDICINES | |
| RU2155584C2 (en) | Use of selegiline for treatment of patients with epileptic disease | |
| RU2004112422A (en) | ROUVASTATIN IN PREDEDENTIONAL CONDITIONS | |
| EP1752147A4 (en) | MEDICINE FOR THE PREVENTION OR TREATMENT OF DIABETES | |
| WO2003066806A3 (en) | Therapeutic use of aziridino compounds | |
| US20030191188A1 (en) | Method for treating migraine symptoms with ibuprofen and salts thereof | |
| CA2030421C (en) | Agent for treatment of cerebrovascular contraction | |
| DE69941431D1 (en) | A compound which inhibits the binding of a protein to mouse cells, the use of the compound for the preparation of a medicament, and a pharmaceutical composition | |
| TH55145A3 (en) | Methods for preventing the onset of asthma | |
| Swick | Intravenous urography by means of the sodium salt of 5-iodo-2-pyridon-N-acetic acid. From the Journal of the American Medical Association, Nov. 8, 1930, Vol. 95, pp. 1403-1409 | |
| RU2004108117A (en) | NEPTIDYLARGINALS AND METHODS OF TREATMENT OF DISSEMINATED INTRAVASCULAR COAGING SYNDROME |